MATRISYS BIOSCIENCE
MatriSys sees commercialization paths for its intellectual property in topical dermatology therapeutics, cosmetics, and skin care. The company’s lead live biologic therapeutic is currently in Phase I/II clinical trials targeting atopic dermatitis (commonly referred to as AD or eczema) patients.
MATRISYS BIOSCIENCE
Industry:
Biopharma Biotechnology Health Care Medical Pharmaceutical
Founded:
2015-01-01
Address:
La Jolla, California, United States
Country:
United States
Website Url:
http://www.matrisysbio.com
Total Employee:
1+
Status:
Active
Contact:
(858)456-3919
Email Addresses:
[email protected]
Total Funding:
4.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Font Awesome WordPress 6.0 Typekit
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Primer Capital
Primer Capital investment in Venture Round - MatriSys Bioscience
Tech Coast Angels
Tech Coast Angels investment in Venture Round - MatriSys Bioscience
Tech Coast Angels
Tech Coast Angels investment in Venture Round - MatriSys Bioscience
Primer Capital
Primer Capital investment in Seed Round - MatriSys Bioscience
Tech Coast Angels
Tech Coast Angels investment in Venture Round - MatriSys Bioscience
Official Site Inspections
http://www.matrisysbio.com
- Host name: dp-dfa6319473.dreamhostps.com
- IP address: 107.180.246.67
- Location: Brea United States
- Latitude: 33.9339
- Longitude: -117.8854
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 92821
More informations about "MatriSys Bioscience"
Toggle Menu
MatriSys is developing a deep pipeline to treat the millions of children and adults suffering from difficult to treat chronic skin diseases.See details»
About Us - MatriSys Bio
MatriSys Bioscience is leading the discovery and clinical development of a novel class of biopharmaceuticals to transform the treatment of chronic skin diseases.See details»
About Us – [webform] - MatriSys Bio
Our groundbreaking technology platform identifies beneficial bacteria derived from healthy human skin to potentially treat the millions of children and adults suffering from difficult to treat chronic …See details»
MatriSys Bioscience, Inc. | LinkedIn
Harnessing beneficial bacteria to treat chronic inflammatory skin conditions. | MatriSys Bio is a clinical stage Specialty Biopharmaceutical Company focused on the $142 Billion WW dermatology and...See details»
MatriSys Bioscience - Crunchbase Company Profile
MatriSys Bio is a clinical stage Specialty Biopharmaceutical Company. View contacts for MatriSys Bioscience to access new leads and connect with …See details»
MatriSys Bioscience Announces Corporate and Strategic Update
LA JOLLA, Calif., Jan. 4, 2023 /PRNewswire/ -- MatriSys BioScience, a private, clinical-stage pharmaceutical company focused on developing live biotherapeutic products (LBPs) for chronic...See details»
MatriSys Bioscience Raises more than $3 million to …
LA JOLLA, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- MatriSys Bioscience, a company harnessing beneficial bacteria to treat inflammatory skin diseases, today announced that it has raised more than...See details»
MatriSys Bioscience Raises more than $3 million to Advance its ...
LA JOLLA, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- MatriSys Bioscience, a company harnessing beneficial bacteria to treat inflammatory skin diseases, today announced that it has …See details»
MatriSys Bioscience is pleased to announce the appointment
May 19, 2020 · MatriSys Bioscience is a clinical stage Specialty Biopharmaceutical Company focused on developing and commercializing rational microbiome therapies for the top five …See details»
Our Science - MatriSys Bio
Using the discovery platform based on leading research from the Gallo Laboratory at the University of California San Diego, MatriSys is able to screen thousands of microbes on the …See details»
Philippe Calais - President, Chi.. - MatriSys Bioscience - ZoomInfo
President, Chief Executive Officer & Director, At Matrisys Bioscience, Inc at MatriSys Bioscience. Philippe Calais has more than 35 years’ experience managing across functions of the drug …See details»
MatriSys Bioscience to Present at the 4th Microbiome
Jul 29, 2021 · MatriSys Bioscience is leading the discovery and clinical development of a novel class of biopharmaceuticals to transform the treatment of inflammatory skin diseases.See details»
MatriSys Bioscience Announces Corporate and Strategic Update
LA JOLLA, Calif., Jan. 4, 2023 /PRNewswire/ — MatriSys BioScience, a private, clinical-stage pharmaceutical company focused on developing live biotherapeutic products (LBPs) for …See details»
MatriSys Bioscience - Overview, News & Similar companies
Jul 29, 2021 · View MatriSys Bioscience (www.cennabiosciences.com) location in California, United States , revenue, industry and description. Find related and similar companies as well …See details»
MatriSys Bioscience names Dr. Phillipe Calais as its New Chief ...
Dec 1, 2020 · clinical stage biotechnology company developing mitochondria-based therapeutics (MBTs) to treat age-related diseases. He also founded and served as Chief Executive Officer …See details»
MatriSys Bioscience, Inc. - Facebook
MatriSys Bioscience, Inc. 1,186 likes. MatriSys Bio is a clinical stage Skin Microbiome Company focused on the $142 Billion WW dermatology and skin care...See details»
MatriSys Bioscience Inc. is pleased to announce that we
May 28, 2020 · MatriSys Bioscience is a clinical stage Specialty Biopharmaceutical Company focused on developing and commercializing rational microbiome therapies for the top five …See details»
Matrisys Bioscience-动脉网
MatriSys Bioscience正在引领一类新型生物制药的发现和临床开发，以改变炎症性皮肤病的治疗。我们突破性的技术平台从健康的人类皮肤中识别出有益细菌，用于治疗数百万患有难以治疗的 …See details»
MatriSys Bioscience announces corporate and strategic update
Jan 3, 2023 · MatriSys Bioscience’s groundbreaking technology platform identifies beneficial bacteria selected from human skin and develops these into treatments for chronic …See details»
MatriSys Bioscience - VentureRadar
Website: http://matrisysbio.com Develops microbiome therapies for dermatology and skin care conditions such as acne, atopic dermatitis, rosacea, psoriasis, and skin infections. Offers …See details»